RecruitingPhase 2NCT04751409

Evaluating the Impact of Limited Compared With Intense Post-Operative Surveillance on Patient-Reported Outcomes in Patients With Stage II-III Soft Tissue Sarcoma of the Trunk and Extremities

Evaluating the Impact of Limited vs. Intense Post-Operative Surveillance on Patient-Reported Outcomes in Patients With Soft Tissue Sarcoma

Sponsor

M.D. Anderson Cancer Center

Enrollment

227 participants

Start Date

Dec 28, 2020

Study Type

INTERVENTIONAL

Conditions

Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 Stage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 Stage IIIA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 Stage IIIB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8

Summary

This phase II trial studies how anxiety is affected by 2 types of follow-up after surgery, limited follow-up and intense follow-up, in patients with stage II-III soft tissue sarcoma of the trunk and extremities. In cancer survivors, the fear of cancer coming back (recurring) is common and may persist long after the end of treatment. It may also be exacerbated by return visits for imaging (surveillance). The purpose of this study is to determine how patients' anxiety and other cancer-related outcomes are affected by how often surveillance is done.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study compares two follow-up monitoring schedules after treatment for soft tissue sarcoma — one with limited check-ups and one with intensive surveillance — to see which has a better effect on patients' quality of life and emotional wellbeing. **You may be eligible if...** - You are 18 years or older - You have been diagnosed with stage II or III soft tissue sarcoma of the trunk or limbs - You completed your main sarcoma treatment (surgery, radiation, or chemotherapy) within the past 8 to 14 weeks - You are willing to complete surveys over 2 years **You may NOT be eligible if...** - Your cancer has spread to other parts of the body (metastatic disease) - You are not able to communicate in English Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREChest Radiography

Undergo CXR

PROCEDUREComputed Tomography

Undergo CT-chest

PROCEDUREFollow-Up

Undergo intense follow-up

PROCEDUREFollow-Up

Undergo limited follow-up

PROCEDUREImaging Technique

Undergo imaging

OTHERQuestionnaire Administration

Ancillary studies

Locations(1)

M D Anderson Cancer Center

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04751409

Related Trials

Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas

NCT06422806248 locations

Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma

NCT064986481 location